APO Research
Talk to an analyst

APO RESEARCH · REPORT

Animal Prescription Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Animal Prescription Drugs Market Outlook and Growth Opportunities 2026

22 December 2025199 pages

Choose your research edition.

Industry ResearchAnimal Prescription Drugs Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Animal Prescription Drugs Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Animal Prescription Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Animal Prescription Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Animal Prescription Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Animal Prescription Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Animal Prescription Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Animal Prescription Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Animal Prescription Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Animal Prescription Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Animal Prescription Drugs market include Zoetis, Virbac, Vetoquinol, Ourofino Saude Animal, MSD Animal Health, Elanco Animal Health, Dechra, Ceva Sante Animale and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Animal Prescription Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Animal Prescription Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Animal Prescription Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Animal Prescription Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Animal Prescription Drugs Segment by Company

Zoetis

Virbac

Vetoquinol

Ourofino Saude Animal

MSD Animal Health

Elanco Animal Health

Dechra

Ceva Sante Animale

Boehringer Ingelheim

Animalcare Group

Animal Prescription Drugs Segment by Type

Injection Type

Smear Type

Spray Type

Oral Type

Animal Prescription Drugs Segment by Application

Companion Animal

Livestock Animal

Animal Prescription Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Animal Prescription Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Animal Prescription Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Animal Prescription Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Animal Prescription Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Prescription Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal Prescription Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Prescription Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Animal Prescription Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Animal Prescription Drugs industry.

Chapter 3: Detailed analysis of Animal Prescription Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Animal Prescription Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Animal Prescription Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Animal Prescription Drugs Industry Trends Table 2. Animal Prescription Drugs Industry Drivers Table 3. Animal Prescription Drugs Industry Opportunities and Challenges Table 4. Animal Prescription Drugs Industry Restraints Table 5. Global Animal Prescription Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Animal Prescription Drugs Revenue Share by Company (2021-2026) Table 7. Global Animal Prescription Drugs Sales Volume by Company (k units) & (2021-2026) Table 8. Global Animal Prescription Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Animal Prescription Drugs Average Price (US$/unit) of Company (2021-2026) Table 10. Global Animal Prescription Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Animal Prescription Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Animal Prescription Drugs Company, Product Type & Application Table 13. Global Animal Prescription Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Animal Prescription Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injection Type Table 18. Significant Companies of Smear Type Table 19. Significant Companies of Spray Type Table 20. Significant Companies of Oral Type Table 21. Global Animal Prescription Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Animal Prescription Drugs Sales Volume by Type (2021-2026) & (k units) Table 23. Global Animal Prescription Drugs Sales Volume by Type (2027-2032) & (k units) Table 24. Global Animal Prescription Drugs Sales Volume Share by Type (2021-2026) Table 25. Global Animal Prescription Drugs Sales Volume Share by Type (2027-2032) Table 26. Global Animal Prescription Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Animal Prescription Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Animal Prescription Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Animal Prescription Drugs Sales Value Share by Type (2021-2026) Table 30. Global Animal Prescription Drugs Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Companion Animal Table 32. Significant Companies of Livestock Animal Table 33. Global Animal Prescription Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Animal Prescription Drugs Sales Volume by Application (2021-2026) & (k units) Table 35. Global Animal Prescription Drugs Sales Volume by Application (2027-2032) & (k units) Table 36. Global Animal Prescription Drugs Sales Volume Share by Application (2021-2026) Table 37. Global Animal Prescription Drugs Sales Volume Share by Application (2027-2032) Table 38. Global Animal Prescription Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Animal Prescription Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Animal Prescription Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Animal Prescription Drugs Sales Value Share by Application (2021-2026) Table 42. Global Animal Prescription Drugs Sales Value Share by Application (2027-2032) Table 43. Global Animal Prescription Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Animal Prescription Drugs Sales by Region (2021-2026) & (k units) Table 45. Global Animal Prescription Drugs Sales Market Share by Region (2021-2026) Table 46. Global Animal Prescription Drugs Sales by Region (2027-2032) & (k units) Table 47. Global Animal Prescription Drugs Sales Market Share by Region (2027-2032) Table 48. Global Animal Prescription Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Animal Prescription Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Animal Prescription Drugs Sales Value Share by Region (2021-2026) Table 51. Global Animal Prescription Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Animal Prescription Drugs Sales Value Share by Region (2027-2032) Table 53. Global Animal Prescription Drugs Market Average Price (US$/unit) by Region (2021-2026) Table 54. Global Animal Prescription Drugs Market Average Price (US$/unit) by Region (2027-2032) Table 55. Global Animal Prescription Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Animal Prescription Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Animal Prescription Drugs Sales by Country (2021-2026) & (k units) Table 58. Global Animal Prescription Drugs Sales Market Share by Country (2021-2026) Table 59. Global Animal Prescription Drugs Sales by Country (2027-2032) & (k units) Table 60. Global Animal Prescription Drugs Sales Market Share by Country (2027-2032) Table 61. Global Animal Prescription Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Animal Prescription Drugs Sales Value Market Share by Country (2021-2026) Table 63. Global Animal Prescription Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Animal Prescription Drugs Sales Value Market Share by Country (2027-2032) Table 65. Zoetis Company Information Table 66. Zoetis Business Overview Table 67. Zoetis Animal Prescription Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Zoetis Animal Prescription Drugs Product Portfolio Table 69. Zoetis Recent Development Table 70. Virbac Company Information Table 71. Virbac Business Overview Table 72. Virbac Animal Prescription Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Virbac Animal Prescription Drugs Product Portfolio Table 74. Virbac Recent Development Table 75. Vetoquinol Company Information Table 76. Vetoquinol Business Overview Table 77. Vetoquinol Animal Prescription Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Vetoquinol Animal Prescription Drugs Product Portfolio Table 79. Vetoquinol Recent Development Table 80. Ourofino Saude Animal Company Information Table 81. Ourofino Saude Animal Business Overview Table 82. Ourofino Saude Animal Animal Prescription Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Ourofino Saude Animal Animal Prescription Drugs Product Portfolio Table 84. Ourofino Saude Animal Recent Development Table 85. MSD Animal Health Company Information Table 86. MSD Animal Health Business Overview Table 87. MSD Animal Health Animal Prescription Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. MSD Animal Health Animal Prescription Drugs Product Portfolio Table 89. MSD Animal Health Recent Development Table 90. Elanco Animal Health Company Information Table 91. Elanco Animal Health Business Overview Table 92. Elanco Animal Health Animal Prescription Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Elanco Animal Health Animal Prescription Drugs Product Portfolio Table 94. Elanco Animal Health Recent Development Table 95. Dechra Company Information Table 96. Dechra Business Overview Table 97. Dechra Animal Prescription Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Dechra Animal Prescription Drugs Product Portfolio Table 99. Dechra Recent Development Table 100. Ceva Sante Animale Company Information Table 101. Ceva Sante Animale Business Overview Table 102. Ceva Sante Animale Animal Prescription Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Ceva Sante Animale Animal Prescription Drugs Product Portfolio Table 104. Ceva Sante Animale Recent Development Table 105. Boehringer Ingelheim Company Information Table 106. Boehringer Ingelheim Business Overview Table 107. Boehringer Ingelheim Animal Prescription Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Boehringer Ingelheim Animal Prescription Drugs Product Portfolio Table 109. Boehringer Ingelheim Recent Development Table 110. Animalcare Group Company Information Table 111. Animalcare Group Business Overview Table 112. Animalcare Group Animal Prescription Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Animalcare Group Animal Prescription Drugs Product Portfolio Table 114. Animalcare Group Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Animal Prescription Drugs Distributors List Table 118. Animal Prescription Drugs Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Animal Prescription Drugs Product Image Figure 2. Global Animal Prescription Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Animal Prescription Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Animal Prescription Drugs Sales (2021-2032) & (k units) Figure 5. Global Animal Prescription Drugs Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Animal Prescription Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injection Type Image Figure 10. Smear Type Image Figure 11. Spray Type Image Figure 12. Oral Type Image Figure 13. Global Animal Prescription Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Animal Prescription Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Animal Prescription Drugs Sales Volume Share by Type (2021-2032) Figure 16. Global Animal Prescription Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Animal Prescription Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Animal Prescription Drugs Sales Value Share by Type (2021-2032) Figure 19. Companion Animal Image Figure 20. Livestock Animal Image Figure 21. Global Animal Prescription Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Animal Prescription Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Animal Prescription Drugs Sales Volume Share by Application (2021-2032) Figure 24. Global Animal Prescription Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Animal Prescription Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Animal Prescription Drugs Sales Value Share by Application (2021-2032) Figure 27. Global Animal Prescription Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Animal Prescription Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Animal Prescription Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Animal Prescription Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Animal Prescription Drugs Sales Value (2021-2032) & (US$ Million) Figure 32. North America Animal Prescription Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Animal Prescription Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Animal Prescription Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Animal Prescription Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Animal Prescription Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Animal Prescription Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. South America Animal Prescription Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Animal Prescription Drugs Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Animal Prescription Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Animal Prescription Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Animal Prescription Drugs Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Animal Prescription Drugs Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Injection Type
  • Smear Type
  • Spray Type
  • Oral Type
Applications
  • Companion Animal
  • Livestock Animal
Companies covered
  • Zoetis
  • Virbac
  • Vetoquinol
  • Ourofino Saude Animal
  • MSD Animal Health
  • Elanco Animal Health
  • Dechra
  • Ceva Sante Animale
  • Boehringer Ingelheim
  • Animalcare Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Animal Prescription Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Animal Prescription Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Animal Prescription Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Animal Prescription Drugs Market Dynamics
  1. 2.1 Animal Prescription Drugs Industry Trends
  2. 2.2 Animal Prescription Drugs Industry Drivers
  3. 2.3 Animal Prescription Drugs Industry Opportunities and Challenges
  4. 2.4 Animal Prescription Drugs Industry Restraints
3 Animal Prescription Drugs Market by Company
  1. 3.1 Global Animal Prescription Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Animal Prescription Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Animal Prescription Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Animal Prescription Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Animal Prescription Drugs Company Ranking (2024-2026)
  6. 3.6 Global Animal Prescription Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Animal Prescription Drugs Company Product Type and Application
  8. 3.8 Global Animal Prescription Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Animal Prescription Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Animal Prescription Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Animal Prescription Drugs Market by Type
  1. 4.1 Animal Prescription Drugs Type Introduction
  2. 4.1.1 Injection Type
  3. 4.1.2 Smear Type
  4. 4.1.3 Spray Type
  5. 4.1.4 Oral Type
  6. 4.2 Global Animal Prescription Drugs Sales Volume by Type
  7. 4.2.1 Global Animal Prescription Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Animal Prescription Drugs Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Animal Prescription Drugs Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Animal Prescription Drugs Sales Value by Type
  11. 4.3.1 Global Animal Prescription Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Animal Prescription Drugs Sales Value by Type (2021-2032)
  13. 4.3.3 Global Animal Prescription Drugs Sales Value Share by Type (2021-2032)
5 Animal Prescription Drugs Market by Application
  1. 5.1 Animal Prescription Drugs Application Introduction
  2. 5.1.1 Companion Animal
  3. 5.1.2 Livestock Animal
  4. 5.2 Global Animal Prescription Drugs Sales Volume by Application
  5. 5.2.1 Global Animal Prescription Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Animal Prescription Drugs Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Animal Prescription Drugs Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Animal Prescription Drugs Sales Value by Application
  9. 5.3.1 Global Animal Prescription Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Animal Prescription Drugs Sales Value by Application (2021-2032)
  11. 5.3.3 Global Animal Prescription Drugs Sales Value Share by Application (2021-2032)
6 Animal Prescription Drugs Regional Sales and Value Analysis
  1. 6.1 Global Animal Prescription Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Animal Prescription Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Animal Prescription Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Animal Prescription Drugs Sales by Region (2027-2032)
  5. 6.3 Global Animal Prescription Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Animal Prescription Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Animal Prescription Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Animal Prescription Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Animal Prescription Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Animal Prescription Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Animal Prescription Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Animal Prescription Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Animal Prescription Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Animal Prescription Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Animal Prescription Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Animal Prescription Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Animal Prescription Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Animal Prescription Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Animal Prescription Drugs Sales Value Share by Country, 2025 VS 2032
7 Animal Prescription Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Animal Prescription Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Animal Prescription Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Animal Prescription Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Animal Prescription Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Animal Prescription Drugs Sales by Country (2027-2032)
  6. 7.4 Global Animal Prescription Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Animal Prescription Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Animal Prescription Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Animal Prescription Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Animal Prescription Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Animal Prescription Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Animal Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Animal Prescription Drugs Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Virbac
  8. 8.2.1 Virbac Company Information
  9. 8.2.2 Virbac Business Overview
  10. 8.2.3 Virbac Animal Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Virbac Animal Prescription Drugs Product Portfolio
  12. 8.2.5 Virbac Recent Developments
  13. 8.3 Vetoquinol
  14. 8.3.1 Vetoquinol Company Information
  15. 8.3.2 Vetoquinol Business Overview
  16. 8.3.3 Vetoquinol Animal Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Vetoquinol Animal Prescription Drugs Product Portfolio
  18. 8.3.5 Vetoquinol Recent Developments
  19. 8.4 Ourofino Saude Animal
  20. 8.4.1 Ourofino Saude Animal Company Information
  21. 8.4.2 Ourofino Saude Animal Business Overview
  22. 8.4.3 Ourofino Saude Animal Animal Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ourofino Saude Animal Animal Prescription Drugs Product Portfolio
  24. 8.4.5 Ourofino Saude Animal Recent Developments
  25. 8.5 MSD Animal Health
  26. 8.5.1 MSD Animal Health Company Information
  27. 8.5.2 MSD Animal Health Business Overview
  28. 8.5.3 MSD Animal Health Animal Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 MSD Animal Health Animal Prescription Drugs Product Portfolio
  30. 8.5.5 MSD Animal Health Recent Developments
  31. 8.6 Elanco Animal Health
  32. 8.6.1 Elanco Animal Health Company Information
  33. 8.6.2 Elanco Animal Health Business Overview
  34. 8.6.3 Elanco Animal Health Animal Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Elanco Animal Health Animal Prescription Drugs Product Portfolio
  36. 8.6.5 Elanco Animal Health Recent Developments
  37. 8.7 Dechra
  38. 8.7.1 Dechra Company Information
  39. 8.7.2 Dechra Business Overview
  40. 8.7.3 Dechra Animal Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Dechra Animal Prescription Drugs Product Portfolio
  42. 8.7.5 Dechra Recent Developments
  43. 8.8 Ceva Sante Animale
  44. 8.8.1 Ceva Sante Animale Company Information
  45. 8.8.2 Ceva Sante Animale Business Overview
  46. 8.8.3 Ceva Sante Animale Animal Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Ceva Sante Animale Animal Prescription Drugs Product Portfolio
  48. 8.8.5 Ceva Sante Animale Recent Developments
  49. 8.9 Boehringer Ingelheim
  50. 8.9.1 Boehringer Ingelheim Company Information
  51. 8.9.2 Boehringer Ingelheim Business Overview
  52. 8.9.3 Boehringer Ingelheim Animal Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Boehringer Ingelheim Animal Prescription Drugs Product Portfolio
  54. 8.9.5 Boehringer Ingelheim Recent Developments
  55. 8.10 Animalcare Group
  56. 8.10.1 Animalcare Group Company Information
  57. 8.10.2 Animalcare Group Business Overview
  58. 8.10.3 Animalcare Group Animal Prescription Drugs Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Animalcare Group Animal Prescription Drugs Product Portfolio
  60. 8.10.5 Animalcare Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Animal Prescription Drugs Value Chain Analysis
  2. 9.1.1 Animal Prescription Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Animal Prescription Drugs Sales Mode & Process
  6. 9.2 Animal Prescription Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Animal Prescription Drugs Distributors
  9. 9.2.3 Animal Prescription Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst